Kristian Reich Moon Lake Immunotherapeutics (MLTX) insider trading activity

Kristian Reich is Chief Scientific Officer of MoonLake Immunotherapeutics. Currently has a direct ownership of 0 shares of MLTX, which is worth approximately $0. The most recent transaction as insider was on Dec 19, 2025, when has been sold 35,389 shares (Class C ordinary shares, par value $0.0001 per share) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

Kristian Reich Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 19 2025	SELL Sale (or disposition) back to the issuer	-	35,389 Reduced 100.0%	0 Class C ordinary share...
Dec 19 2025	BUY Conversion of derivative security	-	35,389 Added 50.0%	35,389 Class A ordinary share...
Dec 09 2025	SELL Open market or private sale	$1,052,062 $14.43 p/Share	72,908 Reduced 100.0%	0 Class A ordinary share...
Dec 08 2025	SELL Open market or private sale	$1,960,400 $15.08 p/Share	130,000 Reduced 64.07%	72,908 Class A ordinary share...
Sep 02 2025	SELL Sale (or disposition) back to the issuer	-	48,978 Reduced 58.05%	35,389 Class C ordinary share...
Sep 02 2025	BUY Conversion of derivative security	-	48,978 Added 19.44%	202,908 Class A ordinary share...
Jan 20 2025	SELL Sale (or disposition) back to the issuer	-	111,949 Reduced 57.02%	84,367 Class C ordinary share...

Jan 20 2025	BUY Conversion of derivative security	-	111,949 Added 42.11%	153,930 Class A ordinary share...
Feb 28 2024	SELL Open market or private sale	$1,544,950 $55.0 p/Share	28,090 Reduced 40.09%	41,981 Class A ordinary share...
Feb 27 2024	SELL Open market or private sale	$1,618,705 $55.0 p/Share	29,431 Reduced 29.58%	70,071 Class A ordinary share...
Feb 21 2024	SELL Open market or private sale	$31,465 $55.3 p/Share	569 Reduced 0.57%	99,502 Class A ordinary share...
Feb 20 2024	SELL Open market or private sale	$574,300 $57.43 p/Share	10,000 Reduced 9.09%	100,071 Class A ordinary share...
Feb 16 2024	SELL Open market or private sale	$601,500 $60.15 p/Share	10,000 Reduced 8.33%	110,071 Class A ordinary share...
Feb 15 2024	SELL Open market or private sale	$601,600 $60.16 p/Share	10,000 Reduced 7.69%	120,071 Class A ordinary share...
Feb 14 2024	SELL Open market or private sale	$624,300 $62.43 p/Share	10,000 Reduced 7.14%	130,071 Class A ordinary share...
Oct 01 2023	SELL Sale (or disposition) back to the issuer	-	41,981 Reduced 17.62%	196,316 Class C ordinary share...
Oct 01 2023	BUY Conversion of derivative security	-	41,981 Added 23.06%	140,071 Class A ordinary share...
Apr 05 2023	SELL Sale (or disposition) back to the issuer	-	98,090 Reduced 29.16%	238,297 Class C ordinary share...
Apr 05 2023	BUY Conversion of derivative security	-	98,090 Added 50.0%	98,090 Class A ordinary share...

Kristian Reich

Chief Scientific Officer

Zug, V8

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells MLTX shares.

Notify only if

Value

Insider Trading

Get notified when an Moon Lake Immunotherapeutics insider buys or sells MLTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to MoonLake Immunotherapeutics

Track Activities on MLTX

Account